Multiplex engineering using microRNA-mediated gene silencing in CAR T cells
Giulia Golinelli(University of Modena and Reggio Emilia), Bruce L. Levine(University of Pennsylvania)
Cited by 4
Related Papers
T cell lymphoma and secondary primary malignancy risk after commercial CAR T cell therapy
|Nature Medicine|2024|254
Both CD28 ligands CD80 (B7-1) and CD86 (B7-2) activate phosphatidylinositol 3-kinase, and wortmannin reveals heterogeneity in the regulation of T cell IL-2 secretion
|International Immunology|1995|74
Production of Human CRISPR-Engineered CAR-T Cells
|Journal of Visualized Experiments|2021|19
Production of Human CRISPR-Engineered CAR-T Cells
|Journal of Visualized Experiments|2021|2